Silverback Therapeutics Inc - ESG Rating & Company Profile powered by AI
Full Sustainability analysis of Silverback Therapeutics Inc can be accessed by logging in. This webpage displays a free E,S&G analysis for Silverback Therapeutics Inc. If you are employed by Silverback Therapeutics Inc and you wish to use your ESG rating, please get in touch.
Silverback Therapeutics Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 5.6; made up of an environmental score of 4.0, social score of 6.4 and governance score of 6.4.
5.6
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 579 | Tonix Pharmaceuticals Holding Corp | 5.7 | High |
| 579 | VIVA Biotech Holdings | 5.7 | High |
| 602 | Silverback Therapeutics Inc | 5.6 | High |
| 602 | Celltrion Inc | 5.6 | High |
| 602 | Adaptimmune Therapeutics PLC | 5.6 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Silverback Therapeutics Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Silverback Therapeutics Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Silverback Therapeutics Inc report the average age of the workforce?
Sign up for free to unlockDoes Silverback Therapeutics Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Silverback Therapeutics Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Silverback Therapeutics Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Silverback Therapeutics Inc offer flexible work?
Sign up for free to unlockDoes Silverback Therapeutics Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Silverback Therapeutics Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Silverback Therapeutics Inc conduct supply chain audits?
Sign up for free to unlockDoes Silverback Therapeutics Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Silverback Therapeutics Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Silverback Therapeutics Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Silverback Therapeutics Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Silverback Therapeutics Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Silverback Therapeutics Inc disclose water use targets?
Sign up for free to unlockDoes Silverback Therapeutics Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Silverback Therapeutics Inc have a product recall in the last two years?
Sign up for free to unlockDoes Silverback Therapeutics Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Silverback Therapeutics Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Silverback Therapeutics Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Silverback Therapeutics Inc disclose parental leave metrics?
Sign up for free to unlockDoes Silverback Therapeutics Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Silverback Therapeutics Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Silverback Therapeutics Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Silverback Therapeutics Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Silverback Therapeutics Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Silverback Therapeutics Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Silverback Therapeutics Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Silverback Therapeutics Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Silverback Therapeutics Inc disclose its waste policy?
Sign up for free to unlockDoes Silverback Therapeutics Inc report according to TCFD requirements?
Sign up for free to unlockDoes Silverback Therapeutics Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Silverback Therapeutics Inc disclose energy use targets?
Sign up for free to unlockDoes Silverback Therapeutics Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Silverback Therapeutics Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Silverback Therapeutics Inc
These potential risks are based on the size, segment and geographies of the company.
Silverback Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops tissue targeted therapeutics for the treatment of cancer, chronic viral infections, and other serious diseases. Its lead product candidate is SBT6050, which is in a Phase I/Ib clinical trial, a TLR8 agonist linker-payload conjugated to a HER2-directed monoclonal antibody that targets tumors, such as breast, gastric, and non-small cell lung cancers. The company also focuses on developing SBT6290, a product candidate that is in preclinical stage, which is a TLR8 linker-payload conjugated to a monoclonal antibody that targets Nectin4, which is expressed in bladder, triple negative breast, head and neck, and non-small cell lung cancers. In addition, it engages in developing SBT8230, a TLR8 linker-payload conjugated to an ASGR1 monoclonal antibody that is under development for the treatment of chronic hepatitis B virus infection; and agents that localize therapies to modulate pathways in additional oncology and fibrosis indications using TLR8 and other linker-payloads. Silverback Therapeutics, Inc. was incorporated in 2016 and is headquartered in Seattle, Washington.